BairdDD, HarmonQ, UpsonK, et al.A prospective, ultrasound-based study to evaluate risk factors for uterine fibroid incidence and growth: Methods and results of recruitment. J Womens Health, 2015; 24:907–915.
CoronadoGD, MarshallLM, SchwartzSM. Complications in pregnancy, labor, and delivery with uterine leiomyomas: A population-based study. Obstet Gynecol, 2000; 95:764–769.
BairdDD, DunsonDB, HillMC, CousinsD, SchectmanJM. High cumulative incidence of uterine leiomyoma in black and white women: Ultrasound evidence. Am J Obstet Gynecol, 2003; 188:100–107.
6.
KjerulffKH, LangenbergP, SeidmanJD, StolleyPD, GuzinskiGM. Uterine leiomyomas: Racial differences in severity, symptoms, and age at diagnosis. J Reprod Med, 1996; 41:483–490.
7.
JohansenCT, WangJ, LanktreeMB, et al.Excess of rare variants in genes identified by genome-wide association study of hypertriglyceridemia. Nat Genet, 2010; 42:684–687.
8.
CardozoER, ClarkAD, BanksNK, HenneMB, StegmannBJ, SegarsJH. The estimated annual cost of uterine leiomyomata in the United States. Am J Obstet Gynecol, 2012; 206:211e1–e9.
9.
MarshallLM, SpiegelmanD, BarbieriRL, et al.Variation in the incidence of uterine leiomyoma among premenopausal women by age and race. Obstet Gynecol, 1997; 90:967–973.
10.
KjerulffKH, LangenbergP, GuzinskiGM. The socioeconomic correlates of hysterectomies in the United States. Am J Public Health, 1993; 83:106–108.
11.
WiseLA, PalmerJR, StewartEA, RosenbergL. Age-specific incidence rates for self-reported uterine leiomyomata in the Black Women's Health Study. Obstet Gynecol, 2005; 105:563–568.
12.
ParazziniF, La VecchiaC, NegriE, CecchettiG, FedeleL. Epidemiologic characteristics of women with uterine fibroids: A case-control study. Obstet Gynecol, 1988; 72:853–857.
13.
TemplemanC, MarshallSF, ClarkeCA, et al.Risk factors for surgically removed fibroids in a large cohort of teachers. Fertil Steril, 2009; 92:1436–1446.
14.
SchwartzSM, MarshallLM, BairdDD. Epidemiologic contributions to understanding the etiology of uterine leiomyomata. Environ Health Perspect, 2000; 108:821–827.
15.
LaughlinSK, BairdDD, SavitzDA, HerringAH, HartmannKE. Prevalence of Uterine Leiomyomas in the First Trimester of Pregnancy: An Ultrasound-Screening Study. Obstet Gynecol, 2009; 113:630–635.
16.
MyersSL, BairdDD, OlshanAF, et al.Self-report versus ultrasound measurement of uterine fibroid status. J Womens Health (Larchmt), 2012; 21:285–293.
17.
LippmanSA, WarnerM, SamuelsS, OliveD, VercelliniP, EskenaziB. Uterine fibroids and gynecologic pain symptoms in a population-based study. Fertil Steril, 2003; 80:1488–1494.
18.
MarshEE, EkpoGE, CardozoER, BrocksM, DuneT, CohenLS. Racial differences in fibroid prevalence and ultrasound findings in asymptomatic young women (18–30 years old): A pilot study. Fertil Steril, 2013; 99:1951–1957.
19.
BorgfeldtC, AndolfE. Transvaginal ultrasonographic findings in the uterus and endometrium: Low prevalence of leiomyoma in a random sample of women age 25–40 years. Acta Obstet Gynecol Scand, 2000; 79:202–207.
20.
BowerJK, SchreinerPJ, SternfeldB, LewisCE. Black-white differences in hysterectomy prevalence: The CARDIA study. Am J Public Health, 2009; 99:300–307.
21.
LoutradisD, AntsaklisA, CreatsasG, et al.The validity of gynecological ultrasonography. Gynecol Obstet Invest, 1990; 29:47–50.
22.
DueholmM, LundorfE, HansenES, LedertougS, OlesenF. Accuracy of magnetic resonance imaging and transvaginal ultrasonography in the diagnosis, mapping, and measurement of uterine myomas. Am J Obstet Gynecol, 2002; 186:409–415.
23.
WiseLA, Laughlin-TommasoSK. Uterine Leiomyomata. In: Women and Health. 2nd ed. GoldmanMB, TroisiR, RexrodeKM, eds. San Diego, CA: Academic Press, 2013, pp 285–306.
24.
SilvaMJ, BarrDB, ReidyJA, et al.Urinary levels of seven phthalate metabolites in the U.S. population from the National Health and Nutrition Examination Survey (NHANES) 1999–2000. Environ Health Perspect, 2004; 112:331–338.
25.
AxelradDA, GoodmanS, WoodruffTJ. PCB body burdens in US women of childbearing age 2001–2002: An evaluation of alternate summary metrics of NHANES data. Environmental Research, 2009; 109:368–378.
26.
SjodinA, JonesRS, CaudillSP, WongLY, TurnerWE, CalafatAM. Polybrominated diphenyl ethers, polychlorinated biphenyls, and persistent pesticides in serum from the national health and nutrition examination survey: 2003–2008. Environ Sci Technol, 2014; 48:753–760.
27.
OgdenCL. Disparities in obesity prevalence in the United States: Black women at risk. Am J Clin Nutr, 2009; 89:1001–1002.
28.
EulingSY, Herman-GiddensME, LeePA, et al.Examination of U.S. puberty-timing data from 1940 to 1994 for secular trends: Panel findings. Pediatrics, 2008; 121Suppl 3:S172–S191.
29.
ZadshirA, TareenN, PanD, NorrisK, MartinsD. The prevalence of hypovitaminosis D among U.S. adults: data from the NHANES III. Ethn Dis, 2005; 15:S5–97–101.
30.
BairdDD, NewboldR. Prenatal diethylstilbestrol (DES) exposure is associated with uterine leiomyoma development. Reprod Toxicol, 2005; 20:81–84.
31.
Velez EdwardsDR, BairdDD, HartmannKE. Association of age at menarche with increasing number of fibroids in a cohort of women who underwent standardized ultrasound assessment. Am J Epidemiol, 2013; 178:426–433.
32.
WeuveJ, HauserR, CalafatAM, MissmerSA, WiseLA. Association of exposure to phthalates with endometriosis and uterine leiomyomata: Findings from NHANES, 1999–2004. Environ Health Perspect, 2010; 118:825–832.
33.
SoeborgT, FrederiksenH, AnderssonAM. Considerations for estimating daily intake values of nonpersistent environmental endocrine disruptors based on urinary biomonitoring data. Reproduction, 2014; 147:455–463.
